Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.68 |
| ▸ | MAG | P20916 | 8/20 | 0.66 |
| ▸ | SELP | P16109 | 2/20 | 0.62 |
| ▸ | SELL | P14151 | 1/20 | 0.62 |
| ▸ | SELE | P16581 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13541590 | 0.98 | SIGLEC7 (0.67) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL21064181 | 0.97 | SIGLEC7 (0.68) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL13541582 | 0.97 | SIGLEC7 (0.68) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL12681640 | 0.96 | MAG (0.68) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL13663173 | 0.96 | MAG (0.68) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL16301492 | 0.95 | SIGLEC7 (0.65) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL13663168 | 0.95 | SIGLEC7 (0.71) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL13663175 | 0.95 | SIGLEC7 (0.71) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL15849917 | 0.95 | SIGLEC7 (0.65) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL25124354 | 0.94 | SELP (0.70) | SIGLEC7MAGSELPSELLSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090263858-A1 | Process for synthesis of mucin-type peptides and muc1-related glycopeptides | SHIONOGI & CO., LTD. (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-1801118-A1 | PROCESS FOR SYNTHESIS OF MUCIN-TYPE PEPTIDES AND MUC1-RELATED GLYCOPEPTIDES | SHIONOGI & CO., LTD. (JP) | 2007-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263858-A1 | Process for synthesis of mucin-type peptides and muc1-related glycopeptides | MUC1, VIP, TMPRSS15 | SIGLEC7 59/4885MAG 1590/4885SELP 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.